These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8823825)

  • 1. Clinical strategies for use of the implantable cardioverter defibrillator: the impact of current trials.
    Estes NA
    Pacing Clin Electrophysiol; 1996 Jul; 19(7):1011-5. PubMed ID: 8823825
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of sudden cardiac death.
    Moss AJ
    Hosp Pract (Off Ed); 1992 Nov; 27(11):165-8, 173-6. PubMed ID: 1429940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the patient with an implantable cardioverter-defibrillator in the third millennium.
    Saksena S; Madan N
    Circulation; 2002 Nov; 106(21):2642-6. PubMed ID: 12438286
    [No Abstract]   [Full Text] [Related]  

  • 4. The implantable cardioverter-defibrillator: does everybody need one?
    Raj SR; Sheldon RS
    Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic implantable cardioverter defibrillator therapy in high-risk patients with coronary artery disease.
    Kolettis TM; Saksena S
    Am Heart J; 1994 Apr; 127(4 Pt 2):1164-70. PubMed ID: 7909188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillators in the United States: understanding the benefits and limitations of implantable cardioverter defibrillator therapy based on clinical trial results.
    Gottlieb C; Callans DJ; Marchlinski F
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 1):2016-20. PubMed ID: 9826851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
    Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
    Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing sudden death in coronary cardiomyopathy: implantable defibrillators lead the way.
    Pavia S; Wilkoff BL
    Cleve Clin J Med; 2001 Feb; 68(2):113, 118, 120, 121, 125, 129. PubMed ID: 11220454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug therapy of ventricular arrhythmias - a contemporary perspective].
    Grönefeld GC; Hohnloser SH
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2280-4. PubMed ID: 12397544
    [No Abstract]   [Full Text] [Related]  

  • 11. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA.
    Brouwer IA; Zock PL; Wever EF; Hauer RN; Camm AJ; Böcker D; Otto-Terlouw P; Katan MB; Schouten EG
    Eur J Clin Nutr; 2003 Oct; 57(10):1323-30. PubMed ID: 14506496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Josephson ME; Callans DJ; Buxton AE
    Ann Intern Med; 2000 Dec; 133(11):901-10. PubMed ID: 11103061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of sudden cardiac death: management considerations.
    Domanski MJ
    Curr Opin Cardiol; 2000 Jul; 15(4):304-8. PubMed ID: 11139095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in therapy of cardiac arrhythmias. Current studies--initial results].
    Meinertz T
    Med Klin (Munich); 1997 Apr; 92(4):211-4. PubMed ID: 9221303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
    Grimm W
    Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of sudden cardiac death: the time of your life.
    Prystowsky EN
    Circulation; 2004 Mar; 109(9):1073-5. PubMed ID: 15007016
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.